TRex Bio, Inc. (TRXB) stock
TRXBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026
$13.67−0.43 (-3.05%)
Close on Nov 13, 2026Market cap $17.98MP/E –Yield –
Statistics
No statistics for TRex Bio yet
Statistics are calculated from the financial statements TRex Bio files with the SEC and the daily share price.
See a number that looks wrong?